Home › Forums › Clinical Practice › GLP-1 use in ED-recovered patient with IR › Reply To: GLP-1 use in ED-recovered patient with IR

#1486
Dr. Erin Knopf

    Sounds like a consultation with the other provider is warranted. In these cases, I find “seeking to understand” by being curious can help point out whether this is a worthy use of the medication or not. If “impulsivity with food” was the reason for the recommendation, is the patient endorsing that? If not, how did the other provider form the recommendation? Psychoeducation about the imminent risk of ED relapse if nutritional intake is interfered with (whether from physical aversion to food, decreased intrinsic signals, decreased oral intake with early satiety). In that discussion for Risk/ Benefit, perhaps the other provider will change the recommendation.